Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Mirabegron 50mg + Solifenacine Succinate I.P. 5mg
Dosage Form : Tablet
Packaging Type : Alu-Alu
Packaging : 10x10
Price : ₹599/-
Miratyle S 50/5 Tablet is a combination of Mirabegron (50mg) and Solifenacin Succinate I.P. (5mg), formulated to provide comprehensive management of overactive bladder (OAB) symptoms. Mirabegron, a beta-3 adrenergic agonist, enhances bladder storage capacity by relaxing the detrusor muscle during the storage phase. Solifenacin Succinate, a muscarinic receptor antagonist, reduces involuntary bladder contractions and urgency. Together, these components synergistically alleviate urinary frequency, urgency, and urge incontinence, offering a dual mechanism of action for better symptom control and improved patient compliance.
This dual-action therapy is ideal for patients who experience insufficient symptom relief with monotherapy or who need a broader therapeutic approach to manage OAB. The tablet is designed for once-daily administration, providing convenience and sustained relief throughout the day.
Common side effects may include dry mouth, constipation, increased blood pressure, headache, and dizziness.
For the treatment of overactive bladder (OAB) symptoms, including urinary urgency, increased frequency, and urge incontinence.
Use only under medical supervision. Avoid in patients with severe liver or kidney impairment or uncontrolled hypertension.
Store in a cool, dry place below 30°C, away from light and moisture.
Composition : Mirabegron (25mg)
Composition : Mirabegron (50mg)
Composition : Alfuzosin (10mg) Tablet
Composition : Alfuzosin (10mg) + Dutasteride (0.5mg) Tablet
Composition : Disodium Hydrogen Citrate (1.40gm) Syrup
Composition : Tamsulosin (0.4mg)
Composition : Tamsulosin (0.4mg) + Tadalafil (5mg)
Composition : Ursodeoxycholic Acid (450mg) SR
Composition : Cranberry Extract 200mg + D-Mannose 300mg + Potassium Magnesium Citrate 978mg
Composition : Cranberry Extract(200.0 Mg/15ml)+Potassium Magnesium Citrate(978.0 Mg/15ml)+D Mannose(300.0 Mg/15ml)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation